These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34548909)

  • 1. High expression of Myosin 1g in pediatric acute lymphoblastic leukemia.
    Estrada-Abreo LA; Rodríguez-Cruz L; Garfias-Gómez Y; Araujo-Cardenas JE; Antonio-Andrés G; Salgado-Aguayo AR; Orozco-Ruiz D; Torres-Nava JR; Díaz-Valencia JD; Huerta-Yépez S; Patiño-López G
    Oncotarget; 2021 Sep; 12(19):1937-1945. PubMed ID: 34548909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of Myosin 1g Overexpression in Pediatric Leukemia by Novel Monoclonal Antibodies.
    Rodríguez-Téllez RI; Ribas-Aparicio RM; Patiño-López G
    Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myosin 1g as a high-risk biomarker in a pediatric patient with lineage switch from acute lymphoblastic leukemia to myeloid phenotype.
    Araujo-Cárdenas JE; Rodríguez-Ruiz MA; López-Valdez JA; Rodríguez-Téllez RI; Garfias-Gómez Y; Parra-Ortega I; Patiño-López G
    Bol Med Hosp Infant Mex; 2023; 80(2):135-143. PubMed ID: 37155721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Class I Myosins, molecular motors involved in cell migration and cancer.
    Diaz-Valencia JD; Estrada-Abreo LA; Rodríguez-Cruz L; Salgado-Aguayo AR; Patiño-López G
    Cell Adh Migr; 2022 Dec; 16(1):1-12. PubMed ID: 34974807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myosin 1g regulates cytoskeleton plasticity, cell migration, exocytosis, and endocytosis in B lymphocytes.
    Maravillas-Montero JL; López-Ortega O; Patiño-López G; Santos-Argumedo L
    Eur J Immunol; 2014 Mar; 44(3):877-86. PubMed ID: 24310084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myo1g is an active player in maintaining cell stiffness in B-lymphocytes.
    López-Ortega O; Ovalle-García E; Ortega-Blake I; Antillón A; Chávez-Munguía B; Patiño-López G; Fragoso-Soriano R; Santos-Argumedo L
    Cytoskeleton (Hoboken); 2016 May; 73(5):258-68. PubMed ID: 27106882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myosin 1G (Myo1G) is a haematopoietic specific myosin that localises to the plasma membrane and regulates cell elasticity.
    Olety B; Wälte M; Honnert U; Schillers H; Bähler M
    FEBS Lett; 2010 Feb; 584(3):493-9. PubMed ID: 19968988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric Acute Lymphoblastic Leukemia: Challenges and Controversies in 2000.
    Felix CA; Lange BJ; Chessells JM
    Hematology Am Soc Hematol Educ Program; 2000; ():285-302. PubMed ID: 11701547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myosin 1g Contributes to CD44 Adhesion Protein and Lipid Rafts Recycling and Controls CD44 Capping and Cell Migration in B Lymphocytes.
    López-Ortega O; Santos-Argumedo L
    Front Immunol; 2017; 8():1731. PubMed ID: 29321775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of the proto-oncogene Bmi-1 predicts a poor prognosis in pediatric acute lymphoblastic leukemia.
    Peng HX; Liu XD; Luo ZY; Zhang XH; Luo XQ; Chen X; Jiang H; Xu L
    BMC Cancer; 2017 Jan; 17(1):76. PubMed ID: 28122538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low expression of Toll-like receptors in peripheral blood mononuclear cells of pediatric patients with acute lymphoblastic leukemia.
    Sánchez-Cuaxospa M; Contreras-Ramos A; Pérez-Figueroa E; Medina-Sansón A; Jiménez-Hernández E; Torres-Nava JR; Rojas-Castillo E; Maldonado-Bernal C
    Int J Oncol; 2016 Aug; 49(2):675-81. PubMed ID: 27277333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myosin-IIA regulates leukemia engraftment and brain infiltration in a mouse model of acute lymphoblastic leukemia.
    Wigton EJ; Thompson SB; Long RA; Jacobelli J
    J Leukoc Biol; 2016 Jul; 100(1):143-53. PubMed ID: 26792819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Allogenic transplantation of hematopoietic stem cells in the treatment of children with high-risk acute leukemia].
    Starý J; Kobylka P; Sedlácek P; Komrska V; Vávra V; Syrůcková Z; Smísek P; Hrubá A; Korínková P; Matĕjková E; Cukrová V; Dolezalová L; Loudová M; Sejkorová J; Kvĕch J
    Cas Lek Cesk; 1998 Jun; 137(12):363-7. PubMed ID: 9721472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic Stem Cell Transplantation from HLA-Mismatched Donors for Pediatric Patients with Acute Lymphoblastic Leukemia Treated According to the 2003 BFM and 2007 International BFM Studies: Impact of Disease Risk on Outcomes.
    Dalle JH; Balduzzi A; Bader P; Lankester A; Yaniv I; Wachowiak J; Pieczonka A; Bierings M; Yesilipek A; Sedlaçek P; Ifversen M; Sufliarska S; Toporski J; Glogova E; Poetschger U; Peters C
    Biol Blood Marrow Transplant; 2018 Sep; 24(9):1848-1855. PubMed ID: 29772352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low expression of
    Cui L; Gao C; Wang CJ; Liu SG; Wu MY; Zhang RD; Li ZG
    Pediatr Hematol Oncol; 2020 Nov; 37(8):732-746. PubMed ID: 32804017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characterization of NK cells in Mexican pediatric patients with acute lymphoblastic leukemia: Report from the Mexican Interinstitutional Group for the Identification of the Causes of Childhood Leukemia.
    Valenzuela-Vazquez L; Núñez-Enríquez JC; Sánchez-Herrera J; Jiménez-Hernández E; Martín-Trejo JA; Espinoza-Hernández LE; Medina-Sanson A; Flores-Villegas LV; Peñaloza-González JG; Refugio Torres-Nava J; Espinosa-Elizondo RM; Amador-Sánchez R; Santillán-Juárez JD; Flores-Lujano J; Pérez-Saldívar ML; García-López LR; Castañeda-Echevarría A; Rodríguez-Leyva F; Rosas-Vargas H; Mata-Rocha M; Duarte-Rodríguez DA; Sepúlveda-Robles OA; Mancilla-Herrera I; Mejía-Aranguré JM; Cruz-Munoz ME
    PLoS One; 2020; 15(1):e0227314. PubMed ID: 31951638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission.
    Fouillard L; Labopin M; Gratwohl A; Gluckman E; Frassoni F; Beelen DW; Willemze R; Montserrat E; Blaise D; Atienza AI; Sierra J; Santos M; Gorin NC; Rocha V;
    Haematologica; 2008 Jun; 93(6):834-41. PubMed ID: 18469352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome after first relapse in children with acute lymphoblastic leukemia: a population-based study of 315 patients from the Nordic Society of Pediatric Hematology and Oncology (NOPHO).
    Schroeder H; Garwicz S; Kristinsson J; Siimes MA; Wesenberg F; Gustafsson G
    Med Pediatr Oncol; 1995 Nov; 25(5):372-8. PubMed ID: 7674994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Childhood pre-B cell acute lymphoblastic leukemia with translocation t(1;19)(q21.1;p13.3) and two additional chromosomal aberrations involving chromosomes 1, 6, and 13: a case report.
    Wafa A; As'sad M; Liehr T; Aljapawe A; Al Achkar W
    J Med Case Rep; 2017 Apr; 11(1):94. PubMed ID: 28385156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimal residual disease in childhood acute lymphoblastic leukemia: analysis of patients in continuous complete remission or with consecutive relapse.
    Biondi A; Yokota S; Hansen-Hagge TE; Rossi V; Giudici G; Maglia O; Basso G; Tell C; Masera G; Bartram CR
    Leukemia; 1992 Apr; 6(4):282-8. PubMed ID: 1316978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.